Jack Cuzick

Jack Cuzick

UNVERIFIED PROFILE

Are you Jack Cuzick?   Register this Author

Register author
Jack Cuzick

Jack Cuzick

Publications by authors named "Jack Cuzick"

Are you Jack Cuzick?   Register this Author

99Publications

2296Reads

28Profile Views

Lifestyle behaviours and health measures of women at increased risk of breast cancer taking chemoprevention.

Eur J Cancer Prev 2019 Nov;28(6):500-506

Manchester Breast Centre, Manchester Cancer Research Centre, University of Manchester.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CEJ.0000000000000493DOI Listing
November 2019

Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia.

Cancer Epidemiol Biomarkers Prev 2019 Nov 5;28(11):1816-1824. Epub 2019 Sep 5.

Center for HPV Prevention, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-19-0239DOI Listing
November 2019

Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.

Arch Pathol Lab Med 2019 11 13. Epub 2019 Nov 13.

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney). The New Mexico HPV Pap Registry Steering Committee members and the p16 IHC Study Panel members are listed in the Acknowledgments. Dr Gravitt is currently located at the Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2019-0241-OADOI Listing
November 2019

The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death.

Histopathology 2019 Oct 13;75(4):589-597. Epub 2019 Aug 13.

UK Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13888DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790619PMC
October 2019

The Parkinson's Disease Mendelian Randomization Research Portal.

Mov Disord 2019 Oct 28. Epub 2019 Oct 28.

Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27873DOI Listing
October 2019

Ki-67 is an independent predictor of prostate cancer death in routine needle biopsy samples: proving utility for routine assessments.

Mod Pathol 2019 Sep 11;32(9):1303-1309. Epub 2019 Apr 11.

Department of Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, EC1A 7BE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0268-yDOI Listing
September 2019

Screening performance of abbreviated versions of the UPSIT smell test.

J Neurol 2019 Aug 3;266(8):1897-1906. Epub 2019 May 3.

Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00415-019-09340-x
Publisher Site
http://dx.doi.org/10.1007/s00415-019-09340-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647236PMC
August 2019

Prediction of reader estimates of mammographic density using convolutional neural networks.

J Med Imaging (Bellingham) 2019 Jul 31;6(3):031405. Epub 2019 Jan 31.

University of Manchester, Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1117/1.JMI.6.3.031405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357906PMC
July 2019

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.

Breast Cancer Res Treat 2019 Jul 2;176(1):141-148. Epub 2019 Apr 2.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Charterhouse Square, Barts and The London, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05210-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548748PMC
July 2019

Predicting late recurrence in ER-positive breast cancer.

Authors:
Jack Cuzick

Nat Rev Clin Oncol 2019 07;16(7):406-408

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-019-0228-yDOI Listing
July 2019

A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.

Int J Cancer 2019 Jun 28. Epub 2019 Jun 28.

Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32541DOI Listing
June 2019

A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.

J Breast Imaging 2019 Jun 11;1(2):99-106. Epub 2019 May 11.

University of Virginia, Department of Radiology and Medical Imaging, University of Virginia Health Sciences Center, Charlottesville, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jbi/wbz006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690422PMC
June 2019

Competing Risks for a Diagnosis of Invasive Breast Cancer-Reply.

JAMA Oncol 2019 01;5(1):111

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.5102DOI Listing
January 2019

Molecular progression to cervical precancer, epigenetic switch or sequential model?

Int J Cancer 2018 10 3;143(7):1720-1730. Epub 2018 Jul 3.

Barts and the London School of Medicine, Charterhouse Square, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, London, EC1M 6BQ, United Kindom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31549DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175180PMC
October 2018

Outcome measures in clinical trials of treatments for acute severe haemorrhage.

Trials 2018 Oct 1;19(1):533. Epub 2018 Oct 1.

Clinical Trials Unit, Department of Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13063-018-2900-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167881PMC
October 2018

Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.

JAMA Oncol 2018 09 13;4(9):e180174. Epub 2018 Sep 13.

Kaiser Permanente Washington Health Research Institute, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.0174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143016PMC
September 2018

Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.

Breast Cancer Res 2018 09 4;20(1):103. Epub 2018 Sep 4.

The Breast Cancer Now Toby Robins Research Centre at the Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-018-1040-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122470PMC
September 2018

Use of the concordance index for predictors of censored survival data.

Stat Methods Med Res 2018 08 29;27(8):2359-2373. Epub 2016 Dec 29.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0962280216680245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041741PMC
August 2018

Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews.

Breast Cancer Res Treat 2018 Aug 24;170(3):633-640. Epub 2018 Apr 24.

Leeds Institute of Health Sciences, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9NL, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4775-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022517PMC
August 2018

The Value of Helicobacter Eradication in Long-term Aspirin Users.

Authors:
Jack Cuzick

J Natl Cancer Inst 2018 07;110(7):690-691

Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037066PMC
July 2018

Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5.

J Clin Oncol 2018 07 20;36(19):1941-1948. Epub 2018 Apr 20.

Mitch Dowsett and Andrew Dodson, Royal Marsden Hospital; Mitch Dowsett, Institute of Cancer Research; Ivana Sestak and Jack Cuzick, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom; Meredith M. Regan, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA; Giuseppe Viale, University of Milan; Guiseppe Viale and Marco Colleoni, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital St Gallen, St Gallen, and International Breast Cancer Study Group and Swiss Group for Clinical Cancer Research, Berne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.4258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049399PMC
July 2018

Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ.

Br J Cancer 2018 07 21;119(1):36-39. Epub 2018 Jun 21.

Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41416-018-0120-z
Publisher Site
http://dx.doi.org/10.1038/s41416-018-0120-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035272PMC
July 2018

Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance.

Urol Oncol 2018 06 11;36(6):310.e7-310.e13. Epub 2018 Apr 11.

Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2018.03.011DOI Listing
June 2018

Exploring the prediction performance for breast cancer risk based on volumetric mammographic density at different thresholds.

Breast Cancer Res 2018 06 8;20(1):49. Epub 2018 Jun 8.

Centre for Imaging Science, School of Health Sciences, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-018-0979-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994123PMC
June 2018

Progress in preventive therapy for cancer: a reminiscence and personal viewpoint.

Authors:
Jack Cuzick

Br J Cancer 2018 05 23;118(9):1155-1161. Epub 2018 Apr 23.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0039-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943239PMC
May 2018

Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.

JAMA Oncol 2018 Apr;4(4):476-482

Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.4881DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885189PMC
April 2018

Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer.

J Natl Cancer Inst 2018 02;110(2)

Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK; Centre for Molecular Pathology, Royal Marsden Hospital, London, UK; Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK; The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK; Cellular Pathology, Guy's and St Thomas' NHS Trust, Westminster Bridge Rd, London, UK; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article/110/2/166/4064177
Publisher Site
http://dx.doi.org/10.1093/jnci/djx137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298573PMC
February 2018

A comparison of five methods of measuring mammographic density: a case-control study.

Breast Cancer Res 2018 02 5;20(1):10. Epub 2018 Feb 5.

Prevent Breast Cancer and Nightingale Breast Screening Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Southmoor Road, Wythenshawe, Manchester, M23 9LT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-018-0932-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799922PMC
February 2018

Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UK.

BMC Public Health 2018 01 25;18(1):178. Epub 2018 Jan 25.

Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12889-018-5090-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784727PMC
January 2018

Prognosis vs Treatment Interaction.

Authors:
Jack Cuzick

JNCI Cancer Spectr 2018 Jan 28;2(1):pky006. Epub 2018 Apr 28.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncics/pky006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649762PMC
January 2018

SNPs for breast cancer risk assessment.

Oncotarget 2017 Nov 3;8(59):99211-99212. Epub 2017 Nov 3.

Jack Cuzick: Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.22278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725081PMC
November 2017

A novel and fully automated mammographic texture analysis for risk prediction: results from two case-control studies.

Breast Cancer Res 2017 Oct 18;19(1):114. Epub 2017 Oct 18.

Centre for Imaging Science, School of Health Sciences, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-017-0906-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648465PMC
October 2017

Health Service Accessibility and Risk in Cervical Cancer Prevention: Comparing Rural Versus Nonrural Residence in New Mexico.

J Rural Health 2017 09 24;33(4):382-392. Epub 2016 Aug 24.

Department of Pathology, House of Prevention Epidemiology (HOPE), University of New Mexico Health Sciences Center, Albuquerque, New Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jrh.12202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939944PMC
September 2017

Clinician-Reported Barriers to Implementing Breast Cancer Chemoprevention in the UK: A Qualitative Investigation.

Public Health Genomics 2016 12;19(4):239-49. Epub 2016 Jul 12.

Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000447552DOI Listing
August 2017

Role of quantitative p16 mRNA assay and digital reading of p16 immunostained sections in diagnosis of cervical intraepithelial neoplasia.

Int J Cancer 2017 08 1;141(4):829-836. Epub 2017 Jun 1.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, Charterhouse Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.30783DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949861PMC
August 2017

Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I).

J Clin Oncol 2017 08 29;35(23):2666-2673. Epub 2017 Jun 29.

Samuel George Smith, Leeds Institute of Health Science, University of Leeds, Leeds; Samuel George Smith, Ivana Sestak, and Jack Cuzick, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London; Anthony Howell, Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom; and John Forbes, Calvary Mater Newcastle Hospital, Newcastle, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.7439DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549455PMC
August 2017

Preventing invasive breast cancer using endocrine therapy.

Breast 2017 Aug 8;34 Suppl 1:S47-S54. Epub 2017 Jul 8.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts & The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2017.06.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218009PMC
August 2017

Preventive therapy for cancer.

Authors:
Jack Cuzick

Lancet Oncol 2017 08 26;18(8):e472-e482. Epub 2017 Jul 26.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30536-3DOI Listing
August 2017

Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions.

Oncotarget 2017 Aug 18;8(31):50510-50520. Epub 2017 May 18.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.17984DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584159PMC
August 2017

Estimating efficacy in trials with selective crossover.

Stat Med 2017 07 15;36(15):2333-2346. Epub 2017 Mar 15.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse square, London, EC1M 6BQ, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.7275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485026PMC
July 2017

Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.

J Clin Oncol 2017 Mar 28;35(7):743-750. Epub 2016 Dec 28.

Jack Cuzick, Adam R. Brentnall, Caroline Reuter, and Ivana Sestak, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London; Corrinne Segal, The Institute of Cancer Research; Corrinne Segal, Simone Detre, Elena Lopez-Knowles, and Mitchell Dowsett, Royal Marsden Hospital; Trevor J. Powles, Cancer Centre London, London; Helen Byers and William G. Newman, University of Manchester and Central Manchester Foundation Trust; and Anthony Howell, The Christie NHS Foundation Trust, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.69.8944
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.69.8944DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455424PMC
March 2017

The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.

J Med Genet 2017 02 28;54(2):111-113. Epub 2016 Oct 28.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2016-104125DOI Listing
February 2017

Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.

Ann Intern Med 2017 Jan 15;166(2):118-127. Epub 2016 Nov 15.

From Scientific Institute of Public Health, Brussels, Belgium; Queen Mary University of London, London, United Kingdom; Cleveland Clinic, Cleveland, Ohio; National Cancer Institute, Bethesda, Maryland; and Kaiser Permanente Northern California, San Leandro, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M15-2735DOI Listing
January 2017

Breast-Cancer Tumor Size and Screening Effectiveness.

N Engl J Med 2017 01;376(1):94

Queen Mary University of London, London, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1614282DOI Listing
January 2017

Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines.

Obstet Gynecol 2016 12;128(6):1248-1257

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health & Human Services, Bethesda, Maryland; the Departments of Pathology, Internal Medicine, and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico; Information Management Services Inc., Calverton, Maryland; the Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, United Kingdom; the Division of Gynecologic Oncology, Kaiser Permanente Medical Care Program, Oakland, California; and the Albert Einstein College of Medicine, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000001721DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247269PMC
December 2016

Need for expanded HPV genotyping for cervical screening.

Papillomavirus Res 2016 12 1;2:112-115. Epub 2016 Jun 1.

Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pvr.2016.05.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886893PMC
December 2016

Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy.

J Natl Cancer Inst 2016 11 10;108(11). Epub 2016 Jul 10.

Affiliations of authors: The Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK (RB, MD); Academic Department of Biochemistry, Royal Marsden Hospital, London, UK (RB, MD); Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK (IS, JC); Sividon Diagnostics GmbH, Cologne, Germany (RK, KK, MS, CP); Institute of Pathology, Charité University Hospital and German Cancer Consortium (DKTK), Berlin, Germany (CD); Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria (PD).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241904PMC
November 2016

A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors.

Oncotarget 2016 Nov;7(44):71833-71840

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.12377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342126PMC
November 2016

Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor-Positive Lymph Node-Negative Early-Stage Breast Cancer.

Clin Cancer Res 2016 Oct 1;22(20):5043-5048. Epub 2016 Jun 1.

Molecular Pathology Unit and Centre for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0155DOI Listing
October 2016

A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population-PREDICTORS 4.

J Clin Virol 2016 09 27;82:145-151. Epub 2016 Jul 27.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2016.06.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994427PMC
September 2016

Endometrial cancer risk in postmenopausal breast cancer patients treated with tamoxifen or aromatase inhibitors.

Expert Rev Endocrinol Metab 2016 Sep 31;11(5):425-432. Epub 2016 Jul 31.

a Centre for Cancer Pevention , Queen Mary University of London , London , United Kingdom of Great Britain and Northern Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17446651.2016.1216101DOI Listing
September 2016

Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors.

Breast Cancer Res Treat 2016 08 22;159(1):71-8. Epub 2016 Jul 22.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University, Charterhouse Square, London, EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3868-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010586PMC
August 2016

Validation of a DNA methylation HPV triage classifier in a screening sample.

Int J Cancer 2016 Jun 8;138(11):2745-51. Epub 2016 Feb 8.

Queen Mary University of London, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine, Charterhouse Square, London, EC1M 6BQ, United Kingdom.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.30008
Publisher Site
http://dx.doi.org/10.1002/ijc.30008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832297PMC
June 2016

Ovarian cancer screening: UKCTOCS trial.

Lancet 2016 Jun;387(10038):2602

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, London EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)30847-9DOI Listing
June 2016

Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome.

Br J Cancer 2016 05 21;114(10):1078-83. Epub 2016 Apr 21.

UK Center for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, EC1A 7BE London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.86DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865975PMC
May 2016

Impact of Screening on Breast Cancer Mortality-Response.

Cancer Epidemiol Biomarkers Prev 2016 05;25(5):873

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-16-0170DOI Listing
May 2016

Breast cancer risk feedback to women in the UK NHS breast screening population.

Br J Cancer 2016 04 29;114(9):1045-52. Epub 2016 Mar 29.

Genesis Breast Cancer Prevention Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester, Southmoor Road, Wythenshawe, Manchester M23 9LT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.56DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984905PMC
April 2016

Explaining the Better Prognosis of Screening-Exposed Breast Cancers: Influence of Tumor Characteristics and Treatment.

Cancer Epidemiol Biomarkers Prev 2016 Mar 8;25(3):479-87. Epub 2015 Dec 8.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0804DOI Listing
March 2016

Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On.

Cancer Epidemiol Biomarkers Prev 2016 Mar 8;25(3):455-62. Epub 2015 Dec 8.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0803DOI Listing
March 2016

Differing Perspectives on Breast Cancer Chemoprevention.

JAMA Oncol 2016 Feb;2(2):276-7

Parkside Cancer Centre London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.4406DOI Listing
February 2016

Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention Trial.

J Clin Oncol 2016 Jan 23;34(2):139-43. Epub 2015 Nov 23.

Francesco Spagnolo, Ivana Sestak, and Jack Cuzick, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London; Anthony Howell, Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester, Manchester, United Kingdom; and John F. Forbes, Department of Surgical Oncology, University of Newcastle, Newcastle Mater Hospital, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.4972DOI Listing
January 2016

Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends.

BMJ Open 2016 Jan 21;6(1):e009584. Epub 2016 Jan 21.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2015-009584DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735168PMC
January 2016

Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake.

Ecancermedicalscience 2015 24;9:595. Epub 2015 Nov 24.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2015.595DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664508PMC
December 2015